Modified anti-inflammatory proteins and method of use
AssigneeJames Cook University
InventorsAlex Loukas, Andrew Leech, Darren Pickering
Life of this patent
Estimating the term…
Loading patent…
AssigneeJames Cook University
InventorsAlex Loukas, Andrew Leech, Darren Pickering
Estimating the term…
A modified Ac-TMP-2 protein lacks one or a plurality of acidic C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein and may also lack one or a plurality of N-terminal amino acids while retaining the amino acid sequence C—S—C at or near the N-terminus. The modified Ac-TMP-2 protein may be useful in method and composition for reducing or alleviating inflammation in a subject. Inflammation may be associated with a disease is a disease of the digestive tract such as chronic gastritis or an inflammatory bowel disease such as Crohn's disease or ulcerative colitis, or a disease of the respiratory system, such as asthma, emphysema, chronic bronchitis, and chronic obstructive pulmonary disease.
A modified Ac-TMP-2 protein which lacks one or a plurality of C-terminal amino acids normally present in a full-length or wild-type Ac-TMP-2 protein, or a fragment or derivative thereof of the modified Ac-TMP-2 protein, wherein the modified Ac-TMP-2 protein comprises:
Dependencies are inferred from the claim text.